Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: Tarlatamab Treatment of small cell lung cancer, 12/01/2024 Positive
TO:
Please use this form to send email to PR contact of this press release:
Orphan designation: Tarlatamab Treatment of small cell lung cancer, 12/01/2024 Positive
TO: